Abstract:Objective To investigate the role of macrophage migration inhibitory factor (MIF) in dorsal root ganglion (DRG) mediated neuropathic pain. Methods Animals in all groups were intrathecally catheterized 5 days before surgery. SD rats were randomized into three groups (n = 8): sham group in which rats received all surgical procedure except nerve ligation, CCI group in which rats received CCI and intrathecal injection of 10% DMSO (10 μl per day for 2 weeks), and ISO-1 group in which rates received CCI and intrathecal injection of ISO-1 (30 ug/ul per day for 2 weeks). Mechanical allodynia of the plantar surface of the left hind-paw was tested on 1st d before surgery, 1st d, 3rd d, 5th d, 7th d, 10th d, and 14th d after surgery in all rats (2h after intrathecal injection). The expressions of MIF, TNF-α and IL-1β in DRG were examined by western blot or ELISA on the 7th and 14th day after surgery. The Conduction Velocity (CV) of sciatic nerve was tested on the 14th day after surgery. Results Paw mechanical withdrawal threshold (PMWT) in CCI group was significantly lowered compared with sham group (P < 0.05), which was abolished by treatment of ISO-1 on 5th d, 7th d, 10th d, and 14th d after surgery (P < 0.05). Westernblot and ELISA showed that the expression of MIF, TNF-α, and IL-1β in CCI group was markedly increased in the ipsilateral DRG on the 7th and 14th day after nerve injury when compared with sham group (P < 0.05), which was significantly suppressed by ISO-1 admission (P < 0.01). Electrophysiology test showed that CV was decreased greatly in the CCI group compared with that in sham group while no difference was observed between CCI and ISO-1 groups. Conclusions MIF antagonist ISO-1attenuates tactile allodynia without obvious physical recovery of sciatic nerve through attenuating local inflammation, suggesting that blockage of MIF might be a therapeutic strategy for treating neuropathic pain.